Lartruvo (olaratumab)

pCPA File Number: 21041
Negotiation Status:
Concluded without agreement
Indication(s):
Advanced Soft Tissue Sarcoma
Sponsor/Manufacturer:
Eli Lilly Canada Inc.
CDA-AMC Project Number:
PC0111-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: